Pneumonitis After Precision Oncology Therapies: A Concise Review-Reference-Cited by-同舟云学术

Pneumonitis After Precision Oncology Therapies: A Concise Review

Published:2018-08-01 Issue:1 Volume:1 Page:26-37
ISSN:2590-017X
Container-title:Journal of Immunotherapy and Precision Oncology
language:en
Short-container-title:

Author:

Jain Akash¹,Shannon Vickie R.¹,Sheshadri Ajay¹

Affiliation:

1. Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Abstract

Abstract With greater understanding of the molecular biology of cancer, precision oncology therapies are becoming increasingly prevalent. Adverse events associated with these therapies may cause significant harm to patients if not promptly recognized and treated. In this review, we focus on pneumonitis that occurs as a side effect of treatment with precision oncology agents. We discuss the incidence and time to onset of pneumonitis associated with a broad array of precision oncology agents. We highlight the common patterns of pneumonitis and offer a comprehensive approach to evaluation and treatment with therapy-specific guidelines where available.

Publisher

Innovative Healthcare Institute

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://meridian.allenpress.com/innovationsjournals-JIPO/article-pdf/1/1/26/2873157/i2590-017x-1-1-26.pdf

Reference191 articles.

1. What is the lifetime risk of developing cancer? The effect of adjusting for multiple primaries;Sasieni;Br J Cancer,2011

2. Available from: https://www.cancer.gov/about-cancer/understanding/statistics. [Accessed Mar 8, 2018] .

3. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012

4. Immunotherapy for unresectable stage III non-small-cell lung cancer;Rizvi;N Engl J Med,2017

5. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors;Casanovas;Cancer Cell,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxic and infectious lung injury differential diagnosis specifics in oncohematological patients;Oncohematology;2023-05-30

2. Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2);International Journal of Clinical Oncology;2022-08-24

3. Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge;Lung India;2022

4. Drugs associated with drug-induced interstitial lung diseases;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2021-08-13

5. First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis;Journal of Immunotherapy and Precision Oncology;2021-04-15